TRCT
SRTAW

Tower Research Capital (TRC)’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Tower Research Capital (TRC)’s Portfolio SRTAW Stock Details SRTAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-22
Closed -$9 – 5215
2024
Q4 		$9 Hold
22
– – ﹤0.01% 5624
2024
Q3 		$4 Hold
22
– – ﹤0.01% 5647
2024
Q2 		$4 Hold
22
– – ﹤0.01% 5621
2024
Q1 		$2 Hold
22
– – ﹤0.01% 5810
2023
Q4 		$8 Hold
22
– – ﹤0.01% 5853
2023
Q3 		$5 Hold
22
– – ﹤0.01% 5880
2023
Q2 		$14 Hold
22
– – ﹤0.01% 5935
2023
Q1 		$0 Hold
22
– – ﹤0.01% 5818
2022
Q4 		$0 Hold
22
– – ﹤0.01% 5901
2022
Q3 		$0 Hold
22
– – ﹤0.01% 6065
2022
Q2 		$0 Hold
22
– – ﹤0.01% 6076
2022
Q1 		$0 Hold
22
– – ﹤0.01% 6095
2021
Q4 		$0 Hold
22
– – ﹤0.01% 6138
2021
Q3 		$0 Hold
22
– – ﹤0.01% 5768
2021
Q2 		$0 Buy
+22
New +$48 ﹤0.01% 5475

Other funds holding SRTAW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.57% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Tower Research Capital (TRC)'s SRTAW Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q1 2025, closing a stake of 22 shares — an estimated $9 sold.

Tower Research Capital (TRC) first reported a position in SRTAW in Q2 2021 and held it in 15 quarters. The position peaked at $14 in Q2 2023. 6 funds tracked by Wall St. Rank hold SRTAW as of Q1 2025.

  • Tower Research Capital (TRC) reported no remaining Strata Critical Medical Inc Warrants position as of Q1 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 22 Strata Critical Medical Inc Warrants shares in Q1 2025, an estimated $9.
  • Tower Research Capital (TRC) first reported a position in Strata Critical Medical Inc Warrants in Q2 2021 and held it in 15 quarters.
  • Tower Research Capital (TRC)'s Strata Critical Medical Inc Warrants position peaked at $14 in Q2 2023.
  • 6 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.